SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 120 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,948,000 | +45.0% | 108,513 | -4.7% | 0.02% | +63.6% |
| Q3 2017 | $1,343,000 | +10.2% | 113,822 | -1.9% | 0.01% | +10.0% |
| Q2 2017 | $1,219,000 | -4.5% | 116,067 | 0.0% | 0.01% | -9.1% |
| Q1 2017 | $1,277,000 | -18.8% | 116,067 | 0.0% | 0.01% | -15.4% |
| Q4 2016 | $1,573,000 | -7.9% | 116,067 | -16.3% | 0.01% | 0.0% |
| Q3 2016 | $1,707,000 | +12.2% | 138,700 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $1,522,000 | -44.0% | 138,700 | -44.2% | 0.01% | -50.0% |
| Q1 2016 | $2,716,000 | +232.4% | 248,500 | +426.0% | 0.03% | +225.0% |
| Q4 2015 | $817,000 | +2453.1% | 47,243 | +2865.7% | 0.01% | – |
| Q3 2015 | $32,000 | -99.2% | 1,593 | -99.3% | 0.00% | -100.0% |
| Q2 2015 | $3,821,000 | +68.4% | 232,553 | +59.5% | 0.05% | +80.8% |
| Q1 2015 | $2,269,000 | +35.6% | 145,810 | +24.5% | 0.03% | +36.8% |
| Q4 2014 | $1,673,000 | – | 117,110 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 555,652 | $9,607,000 | 3.06% |
| OBERWEIS ASSET MANAGEMENT INC/ | 96,630 | $1,671,000 | 0.47% |
| JUNCTURE WEALTH STRATEGIES, LLC | 35,281 | $610,000 | 0.46% |
| AWM Investment Company, Inc. | 100,000 | $1,729,000 | 0.34% |
| GLOBEFLEX CAPITAL L P | 65,588 | $1,134,000 | 0.30% |
| NEW AMSTERDAM PARTNERS LLC/NY | 166,479 | $2,878,000 | 0.30% |
| Convergence Investment Partners, LLC | 100,850 | $1,744,000 | 0.20% |
| GSA CAPITAL PARTNERS LLP | 219,881 | $3,802,000 | 0.19% |
| OXFORD ASSET MANAGEMENT LLP | 433,219 | $7,672,000 | 0.18% |
| Zebra Capital Management LLC | 17,720 | $306,000 | 0.17% |